Immobilized viable microbial cells: from the process to the proteome em leader or the cart before the horse

Biotechnology Advances
Guy-Alain Junter, Thierry Jouenne

Abstract

Biotechnological processes based on immobilized viable cells have developed rapidly over the last 30 years. For a long time, basic studies of the physiological behaviour of immobilized cells (IC) have remained in the shadow of the applications. Natural IC structures, i.e. biofilms, are being increasingly investigated at the cellular level owing to their definite importance for human health and in various areas of industrial and environmental relevance. This review illustrates this paradoxical development of research on ICs, starting from the initial rationale for IC emergence and main application fields of the technology--with particular emphasis on those that exploit the extraordinary resistance of ICs to antimicrobial compounds--to recent advances in the proteomic approach of IC physiology.

References

Apr 1, 1985·Antimicrobial Agents and Chemotherapy·J C NickelJ W Costerton
May 1, 1995·Antimicrobial Agents and Chemotherapy·H KumonJ C Nickel
Jun 1, 1993·Applied Microbiology and Biotechnology·R Willaert, G Baron
Mar 1, 1994·The Journal of Antimicrobial Chemotherapy·M J AshbyI A Critchley
Feb 1, 1993·Canadian Journal of Microbiology·M S NawazC E Cerniglia
Jul 1, 1997·Journal of Periodontal Research·T L WrightM W Mittelman
Mar 3, 1999·The Journal of Antimicrobial Chemotherapy·L CoquetT Jouenne
Mar 9, 1999·Trends in Microbiology·M R Brown, J Barker
May 21, 1999·Science·J W CostertonE P Greenberg
Sep 3, 1999·Journal of Clinical Pharmacology·M Habash, G Reid
Sep 24, 1999·Electrophoresis·R A VanBogelenF C Neidhardt
Apr 20, 2000·Enzyme and Microbial Technology·M B AngelovaL S Slokoska
Jun 14, 2000·Current Opinion in Microbiology·M P Washburn, J R Yates
Jun 17, 2000·Trends in Biotechnology·C NicolellaS J Heijnen
Feb 13, 2001·Trends in Microbiology·T F Mah, G A O'Toole
Mar 14, 2001·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·C KönigJ Blaser
Jun 19, 2001·The EMBO Journal·M A Schembri, P Klemm
Dec 1, 2001·FEMS Microbiology Letters·G SvensäterI R Hamilton
Jan 25, 2002·Journal of Bacteriology·Karin SauerDavid G Davies
Apr 5, 2002·Microbes and Infection·Cuong Vuong, Michael Otto
May 23, 2002·FEMS Microbiology Letters·F TrémouletUNKNOWN European Listeria Genome Consortium
Jun 1, 2002·Applied and Environmental Microbiology·Marinda C OosthuizenVolker S Brözel
Jul 18, 2002·Antimicrobial Agents and Chemotherapy·G StoneA Matin
Feb 11, 2003·Research in Microbiology·Jean Marc Ghigo
Mar 27, 2003·Molecular Microbiology·Mark A SchembriPer Klemm
Mar 28, 2003·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Michael HeckerStuart J Cordwell
Jul 3, 2003·Journal of the American Society for Mass Spectrometry·Tina GuinaKimberly A Lee
Aug 21, 2003·Electrophoresis·Xiang LiaoPeitang Huang

❮ Previous
Next ❯

Citations

May 9, 2012·Applied Microbiology and Biotechnology·Marina V Donova, Olga V Egorova
Jan 9, 2013·Applied Microbiology and Biotechnology·Petra ZajkoskaMichal Rosenberg
Apr 7, 2010·Amino Acids·Haixing Li, Yusheng Cao
Feb 22, 2012·Applied Biochemistry and Biotechnology·Marcel Gutiérrez-CorreaGretty K Villena
Jun 13, 2015·Medical Microbiology and Immunology·Arbia KhemiriPascal Cosette
Feb 1, 2012·Acta Biomaterialia·K GlinelT Jouenne
Jan 19, 2010·Biochimica Et Biophysica Acta·Yohan NigaudThierry Jouenne
Mar 6, 2007·Current Opinion in Biotechnology·Christophe Lacroix, Selcuk Yildirim
Apr 12, 2008·Journal of Biomedical Materials Research. Part a·Laetitia BénardGuy-Alain Junter
Mar 19, 2013·Letters in Applied Microbiology·K PospiskovaI Safarik
Mar 11, 2008·Bioresource Technology·Alok Malaviya, James Gomes
Apr 7, 2015·Applied Microbiology and Biotechnology·Katsutoshi HoriHajime Nakatani
Mar 6, 2008·Biotechnology Journal·Djuro Josic, Spomenka Kovac
Feb 6, 2009·The Journal of Orthopaedic and Sports Physical Therapy·Robert Y WangAugustus D Mazzocca
Dec 12, 2018·The Journal of Chemical Physics·Yalun Yu, Jeffery B Klauda
Jun 22, 2012·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Argia AcarreguiRosa M Hernández
Jul 28, 2016·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Joanna ŻurUrszula Guzik
Feb 7, 2021·Materials Science & Engineering. C, Materials for Biological Applications·Yansheng FanHuiquan Wang
Dec 20, 2018·Critical Reviews in Environmental Science and Technology·Bing WangBin Gao
Aug 8, 2006·Journal of Proteome Research·Sébastien Vilain, Volker S Brözel

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Bioinformatics in Biomedicine

Bioinformatics in biomedicine incorporates computer science, biology, chemistry, medicine, mathematics and statistics. Discover the latest research on bioinformatics in biomedicine here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Biofilm & Infectious Disease

Biofilm formation is a key virulence factor for a wide range of microorganisms that cause chronic infections.Here is the latest research on biofilm and infectious diseases.

Biofilms

Biofilms are adherent bacterial communities embedded in a polymer matrix and can cause persistent human infections that are highly resistant to antibiotics. Discover the latest research on Biofilms here.